|
CRKL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.5877999999E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.86464999999414E-05 |
| Normal-vs-Stage2 |
7.878200E-03 |
| Normal-vs-Stage3 |
1.9775000004163E-07 |
| Normal-vs-Stage4 |
2.16860000001873E-06 |
| Stage1-vs-Stage2 |
8.737200E-01 |
| Stage1-vs-Stage3 |
6.699500E-02 |
| Stage1-vs-Stage4 |
1.092170E-01 |
| Stage2-vs-Stage3 |
2.223200E-01 |
| Stage2-vs-Stage4 |
2.029600E-01 |
| Stage3-vs-Stage4 |
8.237800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.8194000000491E-06 |
| Normal-vs-AfricanAmerican |
1.119380E-03 |
| Normal-vs-Asian |
1.318250E-02 |
| Caucasian-vs-AfricanAmerican |
5.711800E-01 |
| Caucasian-vs-Asian |
2.865000E-01 |
| AfricanAmerican-vs-Asian |
2.947400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35570000000074E-05 |
| Normal-vs-Female |
1.72418999999646E-05 |
| Male-vs-Female |
6.976400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.009100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.30039999999021E-06 |
| Normal-vs-Age(61-80Yrs) |
1.3613999999551E-06 |
| Normal-vs-Age(81-100Yrs) |
1.278320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.356000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.365410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.219400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.824400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.513400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.398800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.189900E-02 |
| Classical-VS-Follicular |
6.377600E-04 |
| Classical-VS-Other |
2.505400E-01 |
| Classical-VS-Normal |
9.382100E-04 |
| Tall-VS-Follicular |
9.703600E-01 |
| Tall-VS-Other |
9.860000E-01 |
| Tall-VS-Normal |
1.53746999999038E-05 |
| Follicular-VS-Other |
9.976600E-01 |
| Follicular-VS-Normal |
2.35689999961153E-07 |
| Other-VS-Normal |
1.408060E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.67189999978579E-07 |
| Normal-vs-N1 |
1.206520E-04 |
| N0-vs-N1 |
9.329000E-01 |
|
|
